{
    "clinical_study": {
        "@rank": "40021", 
        "arm_group": {
            "arm_group_label": "Elderly Chemorads", 
            "description": "Elderly patients with Head and Neck Cancer who are Undergoing Chemotherapy"
        }, 
        "biospec_descr": {
            "textblock": "Whole Blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To look at what types of measures can be used to predict how an older person will tolerate\n      chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw\n      to look at the different measures."
        }, 
        "brief_title": "Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Head and Neck Cancer", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Purpose: To identify baseline predictors of change in function over the course of treatment\n      with chemoradiotherapy in patients with head and neck cancer.\n\n      Participants: Patients 65 or older who have an appointment at the North Carolina Cancer\n      Hospital (NCCH) or other participating sites, have planned chemoradiotherapy for head and\n      neck cancer\n\n      Procedures (methods): Consenting subjects will complete a Geriatric Assessment, Functional\n      Assessment of Cancer Therapy - Head and Neck and give a blood sample for CBC and  p16INK4a\n      at the start of their chemoradiotherapy, at week four, at the end and 90 days post therapy.\n      They will also complete a health behavior questionnaire at baseline."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Patients will be eligible for this protocol provided they have an appointment at the\n             North Carolina Cancer Hospital (NCCH), have planned chemoradiotherapy for head and\n             neck cancer (any histology) and consent to complete the Geriatric Assessment.   No\n             exclusions will be made based on gender, ethnicity, performance status or race.\n             Patient must be able to read and speak English.\n\n          -  Signed, IRB approved written informed consent.\n\n          -  Age of at least 65 years.\n\n          -  Enrollment in other studies, both therapeutic and observational, will not result in\n             exclusion.\n\n        Exclusion Criteria\n\n          -  Inability to read and speak English.\n\n          -  Inability to comply with study for any other reason than language"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Elderly (65 and older) patients with Head and Neck Cancer"
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688323", 
            "org_study_id": "LCCC1208", 
            "secondary_id": "12-0805"
        }, 
        "intervention": {
            "arm_group_label": "Elderly Chemorads", 
            "description": "Each subject will be administered the appropriate surveys and blood draws over the course of the study.", 
            "intervention_name": "Collect Blood and Survey Instruments", 
            "intervention_type": "Other", 
            "other_name": [
                "Geriatric Assessment", 
                "FACT-HN", 
                "p16 Expression", 
                "Health Behavior Questionnaire"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Geriatrics", 
            "Oncology", 
            "Biological Markers", 
            "Survey Instruments", 
            "p16", 
            "Geriatric Oncology", 
            "Biological Markers of Aging", 
            "Symptom Assessment", 
            "Cancer", 
            "Older Persons", 
            "Head and Neck Cancer"
        ], 
        "lastchanged_date": "February 26, 2014", 
        "link": {
            "description": "Geriatric Oncology Program at UNC", 
            "url": "http://unclineberger.org/geriatric"
        }, 
        "location": {
            "contact": {
                "email": "shani_alston@med.unc.edu", 
                "last_name": "Shani Alston, MPH", 
                "phone": "919-843-1906"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27514"
                }, 
                "name": "UNC Lineberger Comprehensive Cancer Center"
            }, 
            "investigator": [
                {
                    "last_name": "Jared Weiss, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Hyman Muss, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer", 
        "overall_contact": {
            "email": "shani_alston@med.unc.edu", 
            "last_name": "Shani Alston, MPH", 
            "phone": "919-843-1906"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina", 
            "last_name": "Jared Weiss, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine if there is a significant change in the Instrumental Activities of Daily Living (IADL) subscore of the Geriatric Assessment (GA) from baseline to 90 days post-treatment.", 
            "measure": "Significant Change in Function from Baseline to Post-Treatment", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688323"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To explore the association of baseline measures with time to decline in living status.  (For example, completely independent to requiring home help, or requiring home help to moving to a nursing home, etc.)", 
                "measure": "Explore Association between Baseline Measures and Decline in Living Status", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "To explore the association of baseline measures with the occurrence of any grade 3 or higher toxicity as a consequence of chemoradiotherapy.", 
                "measure": "Explore Association of Baseline Measures with Grade 3 or Higher Toxicity", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "To explore the association of baseline p16 expression with baseline subscores of the Geriatric Assessment.", 
                "measure": "Explore Association of Baseline p16 with Baseline GA Measures", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "To explore changes in p16 expression, GA subscales, and FACT-HN scores over the course of treatment", 
                "measure": "Explore Changes in p16 Expression, GA Subscales and FACT-HN Scores Over Time.", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "To explore the association of baseline measures with change in IADL subscore.", 
                "measure": "Explore Association between Baseline Measures and Changes in IADL Subscore", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}